XM does not provide services to residents of the United States of America.

India's blue-chip indexes slip as financials, IT weigh



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>INDIA STOCKS-India's blue-chip indexes slip as financials, IT weigh</title></head><body>

Updates with levels as of 11:08 a.m. IST

By Hritam Mukherjee and Kashish Tandon

Dec 16 (Reuters) -India's benchmark indexes fellon Monday, weighed down by losses in heavyweight financials and IT stocksahead of the U.S. Federal Reserve's interest rate decision this week.

The Nifty 50 .NSEI was down 0.5%at 24,652 as of 11:08 a.m. IST, while the BSE Sensex .BSESN shed 0.47% to 81,754.6. The benchmarks notchedtheir longest weekly winning run since July on Friday.

On Monday, ten of the 13 major sectors were trading lower.

Investor focus is on the Fed's monetarypolicy decision on Wednesday and the central bank's commentary on further rate cuts.

A 25-basis-point rate reduction is almost certain this week, with the odds at 97%, according to the CME FedWatch tool.

"Now that a September rate cut has happened, and a December one is near certain - there is a question of when and how much at all will Fed cut rates going into 2025 as Donald Trumptakes the helm," said Aishvarya Dadheech, chief investment officer of Fident Asset Management.

Domestic IT firms .NIFTYIT, which earn a bulk of their revenue from the U.S., fell 0.4% on the day, with Tata Consultancy Services TCS.NS dipping 0.5%.

HDFC Bank HDBK.NS, the heaviest stock on the Nifty 50, slipped 0.5%. This also pulled down financials .NIFTYFIN by 0.2%.

Metals .NIFTMET slipped 0.6%, tracking weak global prices after top consumer China's retail sales were weaker than expected in November, keeping pressure on Beijing to ramp up stimulus as it braces for more U.S. trade tariffs under a second Trump administration. MET/L

Tata Steel TISC.NS, JSW Steel JSTL.NS and Hindalco HALC.NS were among the top five percentage loserson the Nifty, each falling about 1%.

The more domestically-focussedsmallcaps .NIFSMCP100 rose 0.5%,while midcaps .NIFMDCP100 gained 0.4%.



Reporting by Hritam Mukherjee and Kashish Tandon in Bengaluru; Editing by Sumana Nandy, Varun H K and Sonia Cheema

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.